Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
32.66M | 52.59M | 33.06M | 27.97M | 13.08M | Gross Profit |
32.66M | 33.89M | 33.06M | 24.04M | 13.16M | EBIT |
6.01M | 6.52M | 8.12M | -4.89M | -1.05M | EBITDA |
0.00 | 7.30M | 8.93M | -4.89M | -928.00K | Net Income Common Stockholders |
1.93M | 4.51M | 5.64M | -4.05M | -642.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
146.32M | 422.14M | 344.85M | 387.92M | 106.81M | Total Assets |
1.30B | 1.38B | 1.18B | 1.09B | 483.38M | Total Debt |
195.53M | 323.32M | 205.81M | 99.95M | 113.81M | Net Debt |
134.17M | 218.12M | 189.71M | -79.61M | 17.71M | Total Liabilities |
1.02B | 1.09B | 904.64M | 952.40M | 434.49M | Stockholders Equity |
285.16M | 281.90M | 279.48M | 141.00M | 48.88M |
Cash Flow | Free Cash Flow | |||
1.25M | 7.39M | 6.00M | -572.00K | -13.97M | Operating Cash Flow |
1.39M | 7.59M | 6.32M | 566.00K | -13.55M | Investing Cash Flow |
28.22M | -100.04M | -323.96M | 25.02M | 50.71M | Financing Cash Flow |
-73.45M | 181.54M | 102.22M | 109.82M | 43.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $63.08M | 9.56 | 10.25% | 2.88% | 12.23% | -25.92% | |
64 Neutral | $12.73B | 9.92 | 7.90% | 78.88% | 12.06% | -7.95% | |
61 Neutral | $58.63M | 6.36 | 10.87% | 2.25% | 8.22% | 111.97% | |
52 Neutral | $64.43M | 10.38 | -3.20% | 1.66% | -3.54% | -138.07% | |
51 Neutral | $55.39M | 158.72 | 0.57% | ― | 11.84% | -120.17% |
On June 2, 2025, Broadway Financial Corporation announced that William A. Longbrake, a member of its Board of Directors, will resign at the company’s Annual Meeting of Stockholders on June 30, 2025. The resignation is not due to any disagreements with the company’s operations, policies, or practices.
On May 28, 2025, Broadway Financial Corporation received a notification from Nasdaq regarding its non-compliance with the Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. The delay is attributed to the need for additional time to determine the value of a Securities Purchase Option Agreement and to complete fair value measurements disclosure. Nasdaq has given the company 60 days from the notice date to submit a compliance plan, with a potential extension until November 17, 2025, if accepted. The notice does not immediately affect the trading of the company’s shares, but further delays could impact its listing status.